Ariel Tenenbaum

Prof. Ariel Tenenbaum

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 September 2011 in International Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
ATAriel Tenenbaum
Ariel Tenenbaum
SMSarah Malkiel
Sarah Malkiel
IWIsaiah D. Wexler
Isaiah D. Wexler
FLFloris Levy-Khademi
Floris Levy-Khademi
SRShoshana Revel-Vilk
Shoshana Revel-Vilk
PSPolina Stepensky
Polina Stepensky
Background. Iron deficiency anemia impacts on cognitive development. The objective of this study was to determine the prevalence of anemia and iron deficiency in children with Down syndrome and identify risk factors for anemia.Methods. We conducted a prolective cross-sectional study of children attending a multidisciplinary Down syndrome medical center. One hundred and forty nine children with Down syndrome aged 0–20 years were enrolled in the study. Information obtained included a medical history, physical and developmental examination, nutritional assessment, and the results of blood tests.Results. Of the patients studied, 8.1% were found to have anemia. Among the 38 children who had iron studies, 50.0% had iron deficiency. In a multivariate analysis, Arab ethnicity and low weight for age were significantly associated with anemia. Gender, height, the presence of an eating disorder, and congenital heart disease were not risk factors for anemia.Conclusions. Children with Down syndrome are at risk for anemia and iron deficiency similar to the general population. Children with Down syndrome should be monitored for anemia and iron deficiency so that prompt intervention can be initiated.

3 June 2020 in BMC Pediatrics
Verified
Journal Article
Open access
PDF file
ATAriel Tenenbaum
Ariel Tenenbaum
AMAsaf Mandel
Asaf Mandel
TDTalia Dor
Talia Dor
ASAlon Sapir
Alon Sapir
OSOrly Sapir-Bodnaro
Orly Sapir-Bodnaro
IWIsaiah D. Wexler
Isaiah D. Wexler
Background: Fetal alcohol spectrum disorder (FASD) is a leading cause of neurodevelopmental disorders. Children in foster care or domestically adopted are at greater risk for FASD. The aim of this study was to determine the prevalence or risk for FASD in a selected population of foster and adopted children. Methods: Children between 2 and 12 years who were candidates for adoption in foster care were evaluated for clinical manifestations and historical features of fetal alcohol spectrum disorder based on established criteria for FASD. Results: Of the 89 children evaluated, 18 had mothers with a confirmed history of alcohol consumption during pregnancy. Two children had fetal alcohol syndrome and one had partial fetal alcohol syndrome. In addition, five had alcohol-related neurodevelopmental disorder, one had alcohol-related birth defects, and a single child had manifestations of both. Of the 71 children in which fetal alcohol exposure could not be confirmed, many had manifestations that would have established a diagnosis of FASD were a history of maternal alcohol consumption obtained. Conclusions: In a population of high-risk children seen in an adoption clinic, many had manifestations associated with FASD especially where prenatal alcohol exposure was established. The reported prevalence in this study is higher than that reported in our previous study of younger children. This is most likely due to the higher number of children diagnosed with alcohol-related neurodevelopmental disorders that typically manifest at an older age.

20 March 2014 in Frontiers in Public Health
Verified
Journal Article
Open access
ATAriel Tenenbaum
Ariel Tenenbaum
RHRana N. Hanna
Rana N. Hanna
DADina Averbuch
Dina Averbuch
IWIsaiah D. Wexler
Isaiah D. Wexler
MCMaor Chavkin
Maor Chavkin
JMJoav Merrick
Joav Merrick
Children with Down syndrome present with multiple medical problems in a higher prevalence compared with the general population, which may lead to hospitalizations. Methods: Analysis of 560 hospitalizations of 162 children aged 0-16 years with Down syndrome at Hadassah Medical Center during the years 1988-2007 compared with data on children in the general population, hospitalized at the same period. Data was collected from patient files and statistical data from the Ministry of Health. Results: Respiratory infections were the leading cause for hospitalization of children with Down syndrome. The number of hospitalizations of children with Down syndrome compared to the number of all children, who were hospitalized was surprisingly similar to their proportion in the general population. Eleven children died during their hospitalization (five heart failure, three sepsis, one respiratory tract infection and one due to complication after surgery). Nine of the eleven had a congenital heart anomaly. Conclusions: Children with Down syndrome can present with complex medical issues and we support the concept of a multidisciplinary team that has experience and knowledge to serve as a "one stop shop" for these individuals and their families, with timely visits in which a comprehensive evaluation is performed, problems attended to and prevention plans applied. In this way we may prevent morbidity, hospitalizations and mortality.

23 August 2018 in Journal of Intellectual Disability Research
Verified
Journal Article
Closed access
PDF file
AFA. Finkelstein
A. Finkelstein
YBY. G. Bachner
Y. G. Bachner
CGC. Greenberger
C. Greenberger
RBR. Brooks
R. Brooks
ATAriel Tenenbaum
Ariel Tenenbaum

1 May 2007 in Journal of Child Neurology
Verified
Journal Article
Closed access
PDF file
MDMuhannad Daana
Muhannad Daana
YNYoram Nevo
Yoram Nevo
ATAriel Tenenbaum
Ariel Tenenbaum
ITIllana Taustein
Illana Taustein
IBItai Berger
Itai Berger
The purpose of this article is to describe an unusual presentation of lamotrigine toxicity in an epileptic child treated on a lower than previously reported dosage. This is a case description of a 5-year-old epileptic girl on lamotrigine monotherapy, which caused toxicity. The child presented with ataxia, drowsiness, and acute confusion after ingesting 500 mg (25 mg/kg/d) in two 250-mg doses 12 hours apart. This was followed by vomiting and seizure exacerbation. Discontinuing lamotrigine, intravenous fluids and observation were the mainstays of therapy. Until now, the reported minimum dose of lamotrigine causing toxicity was 800 mg. In this patient, toxic manifestation occurred after the initial 250 mg. This case report demonstrates the low safety margin in children treated with lamotrigine.

1 January 2014 in Frontiers in Public Health
Verified
Journal Article
Open access
PDF file
HSHassan Abu Saad
Hassan Abu Saad
SESalman Elbedour
Salman Elbedour
EHEyad Halak
Eyad Halak
JMJoav Merrick
Joav Merrick
ATAriel Tenenbaum
Ariel Tenenbaum
Consanguineous Marriage and Intellectual and Developmental Disabilities among Arab Bedouins Children of the Negev Region in Southern Israel: A Pilot Study